Dataset from: COVID-19: A Gray Swan’s Impact on the Adoption of Novel Medical Technologies
Santos, Roberto S.
Lilly, Craig M.
Hafer, Nathaniel S.
Buchholz, Bryan O.
McManus, David D.
UMass Chan AffiliationsUMass Center for Clinical and Translational Science
Department of Medicine
T.H. Chan School of Medicine
adoption of novel medical technologies
Analytical, Diagnostic and Therapeutic Techniques and Equipment
Biomedical Devices and Instrumentation
Health Information Technology
MetadataShow full item record
AbstractThis dataset is used to examine how the COVID-19 pandemic has shifted many providers and patient perspectives related to healthcare and offers an opportunity to investigate potential changes in provider perceptions towards the adoption of novel point-of-care technologies (POCTs).
Permanent Link to this Itemhttp://hdl.handle.net/20.500.14038/28277
Funding and AcknowledgementsThis research was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number U54HL143541 and the National Center to Advance Translational Sciences under award UL1TR001453. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
This dataset supports the following published study: Dunlap, D.R., Santos, R.S., Lilly, C.M. et al. COVID-19: a gray swan’s impact on the adoption of novel medical technologies. Humanities and Social Sciences Communications 9, 232 (2022). DOI: https://doi.org/10.1057/s41599-022-01247-9.